Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection

Journal of Hepatology

Volumn 45, Issue 2, 2006, Pages 190-196

  Inoue, Michiyo ^a   Kanto, Tatsuya ^a   Miyatake, Hideki ^a   Itose, Ichiyo ^a   Miyazaki, Masanori ^a   Yakushijin, Takayuki ^a   Sakakibara, Mitsuru ^a   Kuzushita, Noriyoshi ^a   Hiramatsu, Naoki ^a   Takehara, Tetsuo ^a   Kasahara, Akinori ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Galactosylceramide; Hepatitis C virus; Natural killer T cell; Th1; Th2

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; INTERLEUKIN 13;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL; TH2 CELL;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 33745727289     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.01.034     Document Type: Article

References (32)

1. Houghton M., Weiner A., Han J., Kuo G., and Choo Q.L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14 (1991) 381-388
2. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.C., et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346 (1995) 1006-1007
3. Cramp M.E., Carucci P., Rossol S., Chokshi S., Maertens G., Williams R., et al. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44 (1999) 424-429
4. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., and Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today 21 (2000) 573-583
5. Exley M.A., and Koziel M.J. To be or not to be NKT: natural killer T cells in the liver. Hepatology 40 (2004) 1033-1040
6. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
7. Spada F.M., Koezuka Y., and Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188 (1998) 1529-1534
8. Takahashi T., Chiba S., Nieda M., Azuma T., Ishihara S., Shibata Y., et al. Cutting edge: analysis of human V alpha 24 + CD8 + NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 168 (2002) 3140-3144
9. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391 (1998) 177-181
10. Araki M., Kondo T., Gumperz J.E., Brenner M.B., Miyake S., and Yamamura T. Th2 bias of CD4 + NKT cells derived from multiple sclerosis in remission. Int Immunol 15 (2003) 279-288
11. Sandberg J.K., Fast N.M., Palacios E.H., Fennelly G., Dobroszycki J., Palumbo P., et al. Selective loss of innate CD4( + ) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol 76 (2002) 7528-7534
12. Tahir S.M., Cheng O., Shaulov A., Koezuka Y., Bubley G.J., Wilson S.B., et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol 167 (2001) 4046-4050
13. Motsinger A., Haas D.W., Stanic A.K., Van Kaer L., Joyce S., and Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 195 (2002) 869-879
14. Lucas M., Gadola S., Meier U., Young N.T., Harcourt G., Karadimitris A., et al. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol 77 (2003) 2251-2257
15. Karadimitris A., Gadola S., Altamirano M., Brown D., Woolfson A., Klenerman P., et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci USA 98 (2001) 3294-3298
16. van der Vliet H.J., Molling J.W., von Blomberg B.M., Kolgen W., Stam A.G., de Gruijl T.D., et al. Circulating Valpha24( + )Vbeta11( + ) NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. Clin Immunol 114 (2005) 183-189
17. Fujii S., Shimizu K., Steinman R.M., and Dhodapkar M.V. Detection and activation of human Valpha24 + natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells. J Immunol Methods 272 (2003) 147-159
18. Gumperz J.E., Miyake S., Yamamura T., and Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195 (2002) 625-636
19. Sandberg J.K., Bhardwaj N., and Nixon D.F. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur J Immunol 33 (2003) 588-596
20. DelaRosa O., Tarazona R., Casado J.G., Alonso C., Ostos B., Pena J., et al. Valpha24 + NKT cells are decreased in elderly humans. Exp Gerontol 37 (2002) 213-217
21. de Lalla C., Galli G., Aldrighetti L., Romeo R., Mariani M., Monno A., et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 173 (2004) 1417-1425
22. Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162 (1999) 5584-5591
23. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190 (2004) 1919-1926
24. Wynn T.A. IL-13 effector functions. Annu Rev Immunol 21 (2003) 425-456
25. Kodera T., McGaha T.L., Phelps R., Paul W.E., and Bona C.A. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts. Proc Natl Acad Sci USA 99 (2002) 3800-3805
26. Bertoletti A., D'Elios M.M., Boni C., De Carli M., Zignego A.L., Durazzo M., et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112 (1997) 193-199
27. Shields P.L., Morland C.M., Salmon M., Qin S., Hubscher S.G., and Adams D.H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163 (1999) 6236-6243
28. Harvey C.E., Post J.J., Palladinetti P., Freeman A.J., Ffrench R.A., Kumar R.K., et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 74 (2003) 360-369
29. Apolinario A., Majano P.L., Alvarez-Perez E., Saez A., Lozano C., Vargas J., et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 97 (2002) 2861-2870
30. Durante-Mangoni E., Wang R., Shaulov A., He Q., Nasser I., Afdhal N., et al. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J Immunol 173 (2004) 2159-2166
31. Kawarabayashi N., Seki S., Hatsuse K., Ohkawa T., Koike Y., Aihara T., et al. Decrease of CD56( + )T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32 (2000) 962-969
32. Nuti S., Rosa D., Valiante N.M., Saletti G., Caratozzolo M., Dellabona P., et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24 + T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 28 (1998) 3448-3455